Singapore markets close in 1 hour 6 minutes
Straits Times Index
3,284.46 -8.67 (-0.26%) Nikkei
37,628.48 -831.60 (-2.16%) Hang Seng
17,267.87 +66.60 (+0.39%) FTSE 100
8,080.38 +40.00 (+0.50%) Bitcoin USD
64,041.45 -2,726.88 (-4.08%) CMC Crypto 200
1,386.87 +4.30 (+0.31%)
Axsome Therapeutics, Inc. (AXSM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.37B |
| Enterprise value | 3.17B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 11.95 |
| Price/book (mrq) | 17.65 |
| Enterprise value/revenue | 11.72 |
| Enterprise value/EBITDA | -14.10 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.10 |
| 52-week change 3 | 0.01% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 98.40 |
| 52-week low 3 | 55.02 |
| 50-day moving average 3 | 76.41 |
| 200-day moving average 3 | 74.80 |
Share statistics
| Avg vol (3-month) 3 | 726.47k |
| Avg vol (10-day) 3 | 618.56k |
| Shares outstanding 5 | 47.37M |
| Implied shares outstanding 6 | 47.37M |
| Float 8 | 34.88M |
| % held by insiders 1 | 17.12% |
| % held by institutions 1 | 83.50% |
| Shares short (28 Mar 2024) 4 | 7.65M |
| Short ratio (28 Mar 2024) 4 | 8.86 |
| Short % of float (28 Mar 2024) 4 | 19.44% |
| Short % of shares outstanding (28 Mar 2024) 4 | 16.15% |
| Shares short (prior month 29 Feb 2024) 4 | 7.47M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -88.41% |
| Operating margin (ttm) | -77.68% |
Management effectiveness
| Return on assets (ttm) | -24.86% |
| Return on equity (ttm) | -159.21% |
Income statement
| Revenue (ttm) | 270.6M |
| Revenue per share (ttm) | 5.96 |
| Quarterly revenue growth (yoy) | 193.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -182.45M |
| Net income avi to common (ttm) | -239.24M |
| Diluted EPS (ttm) | -5.27 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 386.19M |
| Total cash per share (mrq) | 8.15 |
| Total debt (mrq) | 186.37M |
| Total debt/equity (mrq) | 97.59% |
| Current ratio (mrq) | 3.63 |
| Book value per share (mrq) | 4.03 |
Cash flow statement
| Operating cash flow (ttm) | -145.08M |
| Levered free cash flow (ttm) | -78.72M |
© 2024 Yahoo. All rights reserved.